featured
Efficacy and Cost-Efficiency of Immunologically Targeted Low-Dose Rituximab Protocol vs Conventional Rheumatoid Arthritis Protocol in Severe Pemphigus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical and Experimental Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of efficacy and cost-efficiency of an immunologically targeted low dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus
Clin Exp Dermatol 2022 Apr 05;[EPub Ahead of Print], N Singh, S Handa, R Mahajan, N Sachdeva, D DeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.